This site is intended for healthcare professionals only
LoginRegister
Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphomaUSFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis
Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 croreTorrent Pharma finally gets CCI nod for acquisition of JB Chemicals
Alembic Pharma secures USFDA approval for Travoprost Ophthalmic SolutionAlembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension
Granules India packaging facility in US successfully completes USFDA inspectionDr Reddy's Labs Srikakulam facility gets EIR from USFDA
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreAbbVie concludes acquisition of Gilgamesh Pharma Bretisilocin
Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates developmentSyngene International invests in peptide lab, advanced automation
Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal DeathsBiocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths
Delhi High CourtAlkem Vs Alchem: Delhi HC Grants Interim Relief to Alkem Labs in Trademark Tussle
Eli Lilly Jaypirca met its primary endpoint in head-to-head Phase 3 study versus ImbruvicaCDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India
Novo Nordisk seeks USFDA approval for once weekly CagriSema for weight managementNovo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart
Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in ChinaBoehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamCDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis
X